Search all trials

Find therapies in clinical trials near you – page 297

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Glycogen storage disease type II

Recruiting

Registered drugNo placebo

Study on the Effects of Avalglucosidase Alfa Enzyme Replacement Therapy in Patients with Pompe Disease

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Avalglucosidase Alfa

Contact Research Centre

Major depression

Recruiting

Registered drugNo placebo

Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

Registered drugNo placebo

Austria

Participants:18–64 years
Substances:Agomelatine

Contact Research Centre

Gastrooesophageal cancer+1

Recruiting

Registered drugNo placebo

Study on Trastuzumab Deruxtecan and Fluorouracil for Patients with HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Atrial fibrillation+2

Recruiting

Registered drug

Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

ABO haemolytic disease of newborn

Recruiting

Investigational

Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Investigational

Austria

Participants:18–64 years
Substances:Nipocalimab

Contact Research Centre

Endometriosis

Recruiting

Registered drug

Study on Esketamine for Treating Chronic Pain in Endometriosis Patients

Registered drug

The Netherlands

Participants:18–64 years
Substances:Ondansetron

Contact Research Centre

Axial spondyloarthritis

Recruiting

InvestigationalNo placebo

Study on Axial Spondyloarthritis Treatment Using Technetium-Labeled Certolizumab Pegol for Patients with Axial Spondyloarthritis

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Technetium (99Mtc) Certolizumab Pegol

Contact Research Centre

Glycogen storage disease type II

Recruiting

Registered drugNo placebo

Study on Gene Therapy with AAV9.LAMP2B for Male Patients with Danon Disease

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Eculizumab

Contact Research Centre

Colon cancer+1

Recruiting

Registered drugNo placebo

Study on the Safety and Feasibility of Bevacizumab-800CW Imaging for Patients with Barrett's Esophagus, Colon Cancer, or Gastrointestinal Dysplasia

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Hormone-refractory prostate cancer+1

Recruiting

Registered drugNo placebo

Study of Gedatolisib and Darolutamide Combination Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

InvestigationalNo placebo

Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Neonatal alloimmune thrombocytopenia

Recruiting

Investigational

Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

Investigational

Belgium

Participants:18–64 years
Substances:Nipocalimab

Contact Research Centre

Find therapies in clinical trials near you – page 297

10 246 trials match your criteria

Glycogen storage disease type II

Study on the Effects of Avalglucosidase Alfa Enzyme Replacement Therapy in Patients with Pompe Disease

Major depression

Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

Gastrooesophageal cancer+1

Study on Trastuzumab Deruxtecan and Fluorouracil for Patients with HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease

Atrial fibrillation+2

Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

ABO haemolytic disease of newborn

Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Endometriosis

Study on Esketamine for Treating Chronic Pain in Endometriosis Patients

Axial spondyloarthritis

Study on Axial Spondyloarthritis Treatment Using Technetium-Labeled Certolizumab Pegol for Patients with Axial Spondyloarthritis

Glycogen storage disease type II

Study on Gene Therapy with AAV9.LAMP2B for Male Patients with Danon Disease

Colon cancer+1

Study on the Safety and Feasibility of Bevacizumab-800CW Imaging for Patients with Barrett's Esophagus, Colon Cancer, or Gastrointestinal Dysplasia

Hormone-refractory prostate cancer+1

Study of Gedatolisib and Darolutamide Combination Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer

Chronic inflammatory demyelinating polyradiculoneuropathy

Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Neonatal alloimmune thrombocytopenia

Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.